Position in PRLD
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$20,550
+$2,710 QoQ
Shares Held
6,009
-2.3% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
23 quarters on record
Voting authority
Sole 40%
Shared 0%
None 60%
Common Shares in PRLD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026FMR LLC holds $49,682,018,247 across 354 Biotechnology names. PRLD ranks #290 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
14,579,166 | $4,823,808,652 | |
| 2 | ARGX |
Argenx SE
|
4,991,034 | $3,644,702,577 | |
| 3 | MRNA |
Moderna, Inc.
|
45,672,024 | $2,320,138,818 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
77,981,253 | $2,160,080,705 | |
| 5 | INSM |
INSMED Inc
|
13,160,167 | $2,151,950,504 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
24,556,637 | $1,843,957,869 | |
| 7 | RPRX |
Royalty Pharma plc
|
25,152,242 | $1,206,553,046 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,518,192 | $1,173,015,865 |
All Filings in PRLD
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $20,550 | 6,009 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $17,840 | 6,152 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $13,102 | 9,099 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $9,034 | 11,167 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $15,542 | 20,238 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $10,840 | 8,502 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $15,769 | 7,618 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $36,480 | 9,575 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $54,747 | 11,550 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $1,130,212 | 264,687 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $15,856,127 | 5,131,433 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $26,730,989 | 5,940,220 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $25,916,064 | 4,546,678 | Shares | Defined | 2023-08-11 | |
| 2022-12-31 | $27,721,134 | 4,589,592 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $30,660,794 | 4,638,547 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $22,461,496 | 4,302,969 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $37,066,157 | 5,371,907 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $73,939,714 | 5,938,933 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $220,489,560 | 7,055,666 | Shares | Defined | 2022-02-14 | |
| 2021-06-30 | $187,598,045 | 6,552,499 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $270,903,794 | 6,252,107 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $301,222,852 | 4,209,963 | Shares | Defined | 2021-02-08 | |
| 2020-09-30 | $94,258,209 | 3,128,384 | Shares | Defined | 2020-11-13 | |
| No filing history on record for this holder in this stock. | ||||||